Oliver Wyman Health Innovation Summit 2024

Lisa Alderson is the Chief Executive Officer of Adela. Lisa is a mission-driven entrepreneur dedicated to improving patient care and advancing the adoption of precision medicine. She has extensive experience creating and scaling innovative, high-growth businesses at the intersection of technology and healthcare with a focus in genomics, digital health, SaaS, telehealth and molecular diagnostics. Previously, she co-founded and served as the CEO of Genome Medical, the leading genomic care delivery company enabling broad-based access to genomic medicine. She is also a co-founder of Clarified Precision Medicine. Prior, Ms. Alderson served as the Chief Commercial Officer and Chief Strategy Officer of Invitae (NYSE: NVTA), a genetic information company, and was part of the start-up team at Genomic Health Inc. (Nasdaq: GHDX). She was previously president and CEO of Crossloop, (acquired by Nasdaq: AVG), president of Cinema Circle Inc., (acquired by Nasdaq: GAIA) and the former manager of strategic planning at The Walt Disney Co. She has an MBA with distinction from Harvard Business School and a B.A. from Colorado State University, where she graduated Summa Cum Laude.

Feyi Olopade Ayodele is CancerIQ’s Founder and Chief Executive Officer. In this role, Feyi is leading CancerIQ’s bold vision to end cancer as we know it by empowering providers and health systems to expand access to precision cancer prevention, early detection & treatment. CancerIQ makes it easy for health systems to use genetic information to get ahead of cancer at scale. Its best-in-class, science-based platform is proven to double genetic counseling service capacity, quadruple genetic testing uptake & significantly improve screening compliance. Under Feyi’s leadership, CancerIQ has grown its provider network to over 200 locations across the county and established a robust ecosystem of leading diagnostic, genomics testing, telehealth, and AI vendors. These efforts have enabled health systems to increase the use of preventive services, generate downstream revenue, improve quality and screening compliance, and shift cancer diagnoses to earlier stages. Concurrently, CancerIQ has helped its life sciences partners get their innovative, life-saving technologies into the hands of more providers. Most recently, Feyi was named a Modern Healthcare Innovator for 2024 and saw CancerIQ listed among the world’s best digital health companies by Newsweek. A trusted expert in the field of precision prevention, Feyi is routinely featured by prominent industry outlets and organizations including HLTH Matters, Forbes, TechCrunch, Health Management Academy, the Association of Cancer Executives, and more. In recognition of her success, Feyi was named to Crain’s Chicago Business 40 under 40 list in 2019 and has won multiple honors including a Chicago Innovation Award, the Chicago Booth New Venture Challenge, a fellowship from Rock health, and the Women Tech Founders Award. In 2022, Feyi closed CancerIQ’s Series B funding round, led by Merck Global Health Innovation Fund and Amgen Ventures, making her one of the most-funded Black female founders of the year. Feyi received both her bachelor’s and MBA from The Wharton School. Prior to CancerIQ, she worked as a management consultant, investor, and investment banker at McKinsey, Actis LLP, and Credit Suisse, respectively.

Ananya Banerjee is the Chief Commercial Officer at Aledade and leads Aledade’s Strategic Payer Partnerships Team, which is responsible for value-based contracting and health plan partnerships. At Aledade, Ananya has championed a culture that seeks to align interests and benefits for patients, practices and payers through value-based care contracts. She has delivered long-term agreements with multiple national payers, and helped add over 60 new contracts with Medicare Advantage, Medicaid and Commercial health plans in her first year. Before joining Aledade, Ananya was an Associate Partner in the healthcare practice at McKinsey & Co, where she focused on growth and value-based care across both payers and providers. In addition to leading engagements, she was a leader at McKinsey's Center for U.S. Health System Reform. After McKinsey, Ananya held several senior roles at UnitedHealth Group, including building and leading the Strategy and Product team at OptumHealth and leading UHC’s re-entry into the Individual Exchange markets. Most recently, Ananya was Chief of Strategic Payor Partnerships at ChenMed. Ananya has an MBA from the University of Michigan and a bachelor’s degree in Industrial Engineering from the Indian Institute of Technology.

Bio coming soon!

Brooke Brownlow is Group Vice President of H-E-B Wellness & Total Rewards. In her role she is responsible for Nutrition Strategy, Primary Care and the H-E-B Health and Wellness product offering both instore and online. She also leads the Total Rewards team including Benefits and Compensation. Brooke began her career with H-E-B in 1991 as Human Resources Manager. Since then, she has held a wide range of roles including Manager of Partner Relations, Director of HR for Supply Chain, VP of Total Rewards, and her current role as Group Vice President of Wellness & Total Rewards. Brooke holds a Bachelor of Arts in Speech Communication from Texas Tech University and a Master of Science in Health Care Transformation from The University of Texas at Austin. She has been the Chairperson of the Board of the Easter Seals of San Antonio since 2010. She has been married to Darrell since 1987 and they have a daughter (Jordan), son (Dustin) and son in law (Cole) who are all attorneys and a grand dog (Jazz). In her spare time, Brooke spends time with her dogs (Dutch and Bailey) and horses (Journey, Jax and Dude), and generally enjoys being in nature.

Dr. Damon Broyles currently serves as Vice President, Clinical Innovation for Mercy Technology Services, the health technology and informatics support arm of Mercy Healthcare and a division of Mercy’s Office of Transformation. In addition, he maintains a practicing clinical role as the Medical Director for the Multi-Cancer Early Detection program and is part of the leadership team advancing Mercy’s Department of Precision Medicine. As a technologist innovator for the past two decades, he has been involved in optimization of a wide variety of enterprise EHR and clinical software platforms to achieve an ideal provider, patient & health system experience in pursuit of high-quality outcomes. Prior to his current position, he served as CMIO for St. Anthony’s hospital and physician organization. Dr. Broyles leads efforts to source, synthesize and integrate new and state of the science technologies and workflows into the larger health system strategy. He is a board-certified diplomate with the American Board of Family Medicine, a fellow of the American Academy of Family Physicians and holds a subspecialty certification in Clinical Informatics from the American Board of Preventive Medicine. Dr. Broyles’s career path has involved cultivating deep relationships with the accelerator and tech startup landscape in the St. Louis region and beyond. He serves as an entrepreneurial and health IT mentor at Sling Health, a biotech and healthcare incubator with roots at Washington University, and is a member of the Arch Grants corporate advisory council. He is a member of the Community of Health Innovation Leaders for the GlobalSTL initiative, the HIMSS Midwest Gateway Chapter BOD and the Missouri Biotechnology BOD. His diverse background at the intersection of digital health, process innovations and biotechnology expertise has led to numerous strategic advisory and board appointments at GRAIL, Cardiodiagnostics, Imperial Diagnostics, Caralyst Health and Zebra. His research leadership includes a Vice-Chair role on the Mercy Board of Research and prior to that service on the IRB.

Edward Chang MD is Professor and Chair of Neurological Surgery at the University of California, San Francisco. Dr. Chang’s clinical expertise is surgical therapies for epilepsy and brain tumors. He specializes in advanced neurophysiologic brain mapping methods, including awake speech and motor mapping, to safely perform neurosurgical procedures in eloquent areas of the brain. His research focuses on the discovery of cortical mechanisms of high-order neurological function in humans. Dr. Chang’s laboratory has demonstrated the detailed functional organization of the human speech cortex and has translated those discoveries towards the development of a speech neuroprosthetic device to restore communication for people living with paralysis. Dr. Chang is recipient of the 2015 Blavatnik National Laureate in Life Sciences, The Winn Prize of the Society of Neurological Surgeons, and was elected to the National Academy of Medicine.

As Senior Vice President of Strategy for Interwell Health, Ariana Chehrazi leads a team focused on developing and executing Interwell Health’s strategic objectives as well as cross-functional project management with the goal of reimagining kidney care to help patients live their best lives. Prior to joining Interwell, Ariana served in a similar position at Cricket Health. She brings experience helping large healthcare organizations define and operationalize their go to market, population health, and change management strategies from having served as Senior Implementation and Account Manager at Optum Analytics (formerly Humedica) and a healthcare consultant at Putnam Associates. Ariana earned a BS in Biology from the Massachusetts Institute of Technology and an MBA in Healthcare Management from The Wharton School.

Alice Hm Chen, MD, MPH, serves as Chief Health Officer (CHO) for Centene Corporation. Dr. Chen is responsible for Centene's strategies, policies and programs in support of improving population health for Centene's members. Prior to joining Centene, Dr. Chen was Chief Medical Officer at Covered California, the state’s health insurance marketplace, where she was responsible for healthcare strategy focused on quality, equity and delivery system transformation. She previously served as Deputy Secretary for Policy and Planning and Chief of Clinical Affairs for the California Health and Human Services Agency, where she led signature health policy initiatives on affordability and access and played a leadership role in the state’s response to the COVID-19 pandemic. Dr. Chen was also a professor of medicine at the University of California San Francisco School of Medicine, based at the Zuckerberg San Francisco General Hospital, where she served as its Chief Integration Officer and founding director of the eConsult program. Dr. Chen received a Bachelor of Science in environmental biology from Yale University and has a Doctor of Medicine from the Stanford University School of Medicine. She also has a Master of Public Health in health care management and policy from Harvard School of Public Health. A primary care internist by training, she provides clinical care at Zuckerberg San Francisco General Hospital.

Sandra Clarke is Executive Vice President and Chief Operating Officer at Blue Shield of California, a nonprofit health plan with over $25 billion in annual revenue serving more than 4.8 million members. She is responsible for the day-to-day operations of the health plan, implementing strategies to deliver transformational results that improve the well-being of Blue Shield’s members, physicians, and communities it serves. Clarke oversees the operations, transformation, customer experience, growth, and marketing functions, in addition to architecting the company’s bold initiative to reimagine the pharmacy care model and reduce the cost of prescription drugs. She also leads corporate development, devising and enacting Blue Shield’s strategies to support growth. Clarke has demonstrated her ability to improve operations in global businesses, with over 25 years of experience directing worldwide organizations in an array of critical industries. Prior to joining Blue Shield in 2018 as chief financial officer, she was senior vice president and US head of finance for pharmaceutical company Daiichi Sankyo, Inc., and held executive finance roles at Philips Healthcare and Siemens Water Technologies Group. She serves on five boards, including: board member of the Blue Shield of California Foundation, chair of Blue Venture Fund V, chair of Plan Investment Fund, board member of Synergie, and board member (former chair) of Evio Pharmacy Solutions. She previously served on the board of Altais and as board director and audit chair at Metromile (now part of Lemonade, Inc.). For her achievements, Clarke was named one of Modern Healthcare’s Women Leaders of 2024. As a recognized thought leader, she has written articles for various publications and has spoken at many prominent forums including a White House Roundtable, Reuters Total Health, Health Evolution Summit, Business Group on Health, AHIP, UCSF Rosenman Symposium, Silicon Valley Leadership Group, and Fierce Healthcare’s Podnosis. Clarke has a Master of Science in healthcare law from Seton Hall University School of Law, a Master of Science in accounting from Bentley University, and a Bachelor of Science in finance from the Massachusetts Institute of Technology.

Brent Davis is Senior Vice President, Chief Operating Officer and Chief Financial Officer for AdventHealth’s Primary Health Division. In this role, Davis oversees the financial and operational strategies for this new division that is orchestrating high-value, longitudinal, whole-person primary health care, including full-risk senior primary health, urgent care and home and hospice care. Prior to joining the Primary Health Division leadership team, Davis was the regional chief financial officer for the AdventHealth facilities in Volusia, Flagler and Lake counties. His former experience includes serving as CFO at Kettering Medical Center System in Ohio, St. Anthony North Hospital in Colorado and AdventHealth Avista, also in Colorado. He began his career as an auditor for Earnst & Young as an auditor in 2008. Davis received a Master of Business Administration with an emphasis in information technology from California Lutheran University and a Bachelor of Business Administration with a concentration in accounting from Walla Walla University. Together with his wife Angela, Davis has two kids, Lincoln (7) and Everly (5). In his spare time, he enjoys water sports, beach days and other opportunities to be outdoors.

Dr. DeCherrie’s professional passion is home based medical care. She is the Vice President, Clinical Strategy and Implementation at Medically Home which is a technology-enabled services company that provides all the necessary tools to allow medical providers to provide hospital at home. Previously she was at Mount Sinai Health system for 18 years and most recently was the Clinical Director of Mount Sinai at Home, the home based service line. The service line includes Mount Sinai Visiting Doctors Program (home based primary and palliative care), Hospitalization at Home, Rehabilitation at Home, Mount Sinai Palliative Care at Home and Pediatrics Visiting Doctors and Complex Care. Dr. DeCherrie is a Clinical Professor in the Brookdale Department of Geriatrics and Palliative Medicine at the Icahn School of Medicine at Mount Sinai. Dr. DeCherrie graduated from University of Chicago in 1995 with a major in History, Philosophy and Social Studies of Science and Medicine (HiPSS) and then continued at Pritzker School of Medicine graduating in 1999. She completed her residency in Internal Medicine at Boston University where she was named chief resident. She then came to Mount Sinai for her fellowship in Geriatrics which she completed in 2005.

Bio coming soon!

Mary Jane Favazza is the Chief Executive Officer (CEO) of CloseKnit, a virtual-first primary care practice that makes high-quality care accessible with 24/7 primary care, urgent care, and mental health support. “We created CloseKnit because people deserve an enhanced, modern care experience that meets their expectations, needs and preferences for choice in how they connect and experience care. Nearly 40% of our members don’t have a primary care doctor. CloseKnit helps fill critical gaps for many patients, particularly those who lack a PCP, including expanding our valued network of providers and making it easy to access the care they seek 24 hours a day, seven days a week.” --Brian D. Pieninck, President and CEO of CareFirst Mary Jane brings nearly 25 years of experience in the healthcare industry. She’s lent her passion and expertise to both start-ups and growth companies. Throughout her career, Mary Jane has focused on patient support, advocacy, and innovation in primary care models and beyond. Prior to joining CloseKnit, she served as General Manager for Haven, a joint venture to provide low-cost, high-quality healthcare. In this role, she was responsible for the company’s primary care and healthcare ecosystem initiatives. She served as Chief Revenue Officer for Good Measures prior to her role at Haven. At Good Measures, she was responsible for company growth and delivering innovative nutrition and condition management programs. Before joining Good Measures, Mary Jane also served as the General Manager for Accolade. There, she focused on improving patient health outcomes and lowering healthcare costs. She also took on the role of Executive Vice President at Health Dialog, a healthcare innovation company focused on using machine learning analytics and patient coaching to help improve health outcomes and reduce spending.

Dr. Fairchild joined CVS Health in 2019 and is the Chief Medical Officer for Retail Health, and Senior Vice President and Associate CMO within the CVS Health enterprise. In the preceding four years, he was a Director at BDC Advisors, where he led the consulting firm’s physician enterprise strategy practice. Prior to joining BDC Advisors, Dr. Fairchild held various academic medicine positions, most recently serving as Senior Vice President for Clinical Integration at UMass Memorial Health Care (UMMHC), President of the UMass Memorial Accountable Care Organization, and Professor of Medicine at the University of Massachusetts Medical School. Before working at UMMHC, he was Chief Medical Officer at Tufts Medical Center in Boston, and Associate Professor of Medicine at Tufts University School of Medicine. Prior to joining Tufts Medical Center in 2003, Dr. Fairchild was the Director of Primary Care Services at Brigham & Women’s Hospital and Assistant Professor of Medicine at Harvard Medical School. A graduate of Haverford College in Philadelphia and Pennsylvania State University School of Medicine in Hershey Pennsylvania, Dr. Fairchild completed his residency at Yale New Haven Hospital in Connecticut. After an additional year as Chief resident at Yale New Haven Hospital, Dr. Fairchild spent three years on the Navajo Reservation as a physician in the Indian Health Service, serving as the Chief of Staff of his IHS hospital in Chinle, Arizona. Dr. Fairchild earned his MPH from the Harvard School of Public Health in 1995. A practicing board certified general internist for over thirty years, Dr. Fairchild is a Fellow of the American College of Physicians.

Lidia Fonseca is the Chief Digital and Technology Officer at Pfizer, responsible for enterprise-wide digital, data and technology strategy and solutions to support the purpose of delivering Breakthroughs that Change Patients’ Lives. She also leads Learning and Development and Business Process Excellence. In her prior role, Lidia was CIO at Quest Diagnostics, the world’s leading provider of diagnostic information services. Throughout her career, Ms. Fonseca has received numerous awards and accolades, including the 2023 National CIO of the Year ORBIE Award and the 2022 New York CIO of the Year ORBIE Award. She was named on the 2022 Forbes CEO Next List recognizing top 50 executives who are likely to lead some of America’s top companies and the 2022 Forbes CIO Next List recognizing the top 50 tech leaders who are redefining the CIO role and driving game-changing innovation. She was named on the list of the 50 Most Powerful Latinas in 2020, 2021, and 2022 by the Association of Latino Professionals for America. In 2022, Pfizer won multiple awards in digital manufacturing including Gartner’s Supply Chain Breakthrough of the Year Award. She earned a BA from the University of California, Berkeley and an MBA and Master Business Informatics from Rotterdam School of Management, Erasmus Graduate School of Business. Lidia is a member of the Board of Directors of Medtronic (NYSE: MDT) and the U.S.-Japan Business Council. She was previously a member of the Board of Directors at Tegna, Inc. (NYSE: TGNA) from 2014 – August 2023, Gannet, Inc. (NYSE: GCI) from 2014-2017 and Q2 Solutions, a joint venture between Quest Diagnostics and IQVIA, from 2016 to 2018.

Gary Foster, PhD, is the Chief Scientific Officer at WeightWatchers. Dr. Foster, a psychologist, obesity researcher and behavior change expert, was previously the Founder and Director of the Center of Obesity Research and Education and Laura Carnell Professor of Medicine, Public Health and Psychology at Temple University in Philadelphia. Prior to Temple he served as the Clinical Director of the Weight and Eating Disorders Program at the University of Pennsylvania School of Medicine. He has authored more than 250 scientific publications and four books on the causes, prevention and treatment of obesity. His most recent book, The Shift, is a national bestseller. Dr. Foster’s current focus is on scalable, evidence-based approaches to healthy living in community settings. Foster has earned numerous honors including Outstanding Contributions to Health Psychology (American Psychological Association), Award for Distinguished Public Service (The Obesity Society) and Outstanding Scientific Achievements Award in Obesity Research (American Society for Nutrition).

Dr. Elizabeth Fowler is Deputy Administrator and Director of the Center for Medicare and Medicaid Innovation at CMS. Dr. Fowler previously served as Executive Vice President of programs at The Commonwealth Fund and Vice President for Global Health Policy at Johnson & Johnson. Before that, she was special assistant to President Obama on health care and economic policy at the National Economic Council. From 2008 to 2010, she was Chief Health Counsel to Senate Finance Committee Chair, Senator Max Baucus (D-MT), where she played a critical role developing the Senate version of the Affordable Care Act. She also played a key role drafting the 2003 Medicare Prescription Drug, Improvement and Modernization Act (MMA). Dr. Fowler has over 25 years of experience in health policy and health services research. She earned a bachelor’s degree from the University of Pennsylvania, a Ph.D. from the Johns Hopkins Bloomberg School of Public Health, and a law degree (J.D.) from the University of Minnesota. She is admitted to the bar in Maryland, the District of Columbia, and the U.S. Supreme Court. Dr. Fowler is a Fellow of the inaugural class of the Aspen Health Innovators Fellowship and was elected to the National Academy of Medicine in 2022.

Niyum Gandhi is the Chief Financial Officer and Treasurer at Mass General Brigham. His responsibilities include financial oversight for Mass General Brigham’s clinical and academic operations and management within the areas of corporate finance, treasury, managed care, real estate, and supply chain, as well as operational oversight of Mass General Brigham Health Plan. Prior to joining Mass General Brigham and returning to Boston in 2021, Niyum served on the executive team at Mount Sinai Health System in New York. He joined the organization as its first Chief Population Health Officer in 2015. In that role, he built Mount Sinai’s clinically integrated network, direct-to-employer business unit and consumer digital function. He later took on the role of Chief Financial Officer for the health system, overseeing the financial operations of Mount Sinai’s eight hospitals and the Icahn School of Medicine. Before his tenure at Mount Sinai, Niyum was a Partner in the Health and Life Sciences consulting practice of Oliver Wyman, a global management consulting firm, where he focused on financial planning, value-based health care, and transformation strategies for hospitals, physician groups, and health plans. Throughout his career, Niyum has collaborated closely with a variety of health care providers and payers to help design and implement value-based clinical models, develop new contracting and integrated product distribution strategies, align funds flow and physician incentives, and establish the appropriate infrastructure to support value-based health care. Niyum holds an A.B. in economics from Harvard University.

Matthew Gibbs is a pharmacy transformation leader at Blue Shield of California, a nonprofit health plan with over $24 billion in annual revenue serving 4.8 million members in the state's commercial, individual, and government markets. In his role, he leads the company’s Pharmacy Care Reimagined strategic efforts and commercialization. The initiative dismantled the vertically integrated PBM model, replacing it with best-in-class partner solutions to improve transparency and experiences while also generating savings for the health plan and its members. Gibbs has demonstrated his ability to lead organizations through industry-changing events. Before joining Blue Shield of California, he was President of Capital Rx, overseeing operations, client success, clinical services, and government programs. In that role, he provided expert testimony for the U.S. Senate Committee on Finance regarding PBM transparency. Gibbs has also served as President at EnvisionRx, Chief Pharmacy Executive at Anthem (now Elevance Health), Chief Clinical Officer at Medco (now Express Scripts), and Vice President of Sales and Service at Walgreens. Gibbs received his Doctor of Pharmacy degree from Butler University.

Sam Glick is executive vice president of enterprise strategy and business development for Kaiser Foundation Health Plan, Inc. and Hospitals. Glick is responsible for finding ways to bring Kaiser Permanente’s leading model of health-focused care to more communities, customers, and consumers. In support of that goal, he leads strategy, business development, innovation, government relations, communications, and risk management for the organization, including integrated care and coverage, Kaiser Permanente’s national health plan, the KP Medical Foundation, Risant Health, and future new businesses. He also oversees Kaiser Permanente Ventures and Kaiser Permanente International. Raised on a citrus nursery in Southern California, Glick trained in economics at Pomona College in California and the University of Warwick in England. He then worked in the technology industry as an entrepreneur and strategist, and helped to build the strategy and corporate development function at Mercer, the country's largest employer benefits broker and consultant. Immediately prior to joining Kaiser Permanente, he led the global Health & Life Sciences business at Oliver Wyman, working with health systems, health plans, and other health care organizations to be more responsive to market and consumer needs. Glick believes that everyone deserves easy access to high-quality, affordable health care — when, where, and how they want it. He also believes that education and good health go hand in hand. He is a longtime trustee of Pomona College, where he served for 9 years as chair of the board. He also serves as a member of the advisory board for the Rosenman Institute at the University of California, San Francisco, and he and his wife, Emily Glick, serve as cochairs of the Meals on Wheels of San Francisco honorary board.

Bio coming soon!

Camille Harrison is Executive Vice President, Medicare and Chief Innovation and Experience Officer. In this role, she oversees the enterprise’s Medicare company, as well as GuideWell’s Innovation, Customer Experience, and Digital efforts. She also has oversight for Marketing and the Customer Service Center for Florida Blue. Harrison provides overall leadership for Florida Blue Medicare, including positioning and managing the performance of this business segment. She is leading the implementation of a new digital operating model which will enable at-scale digital transformation. Additionally, Harrison leads efforts to establish enterprise-wide metrics and analysis to better understand customer loyalty and develop a common approach for executing work across the organization. Within GuideWell Innovation, she plays a critical role in addressing important company challenges by identifying and delivering strategic, innovative solutions that help the enterprise better serve its members, customers, and communities. Harrison is also responsible for the marketing approach to position Florida Blue as the preferred health solutions company for Floridians, in addition to the company’s customer service strategy. Harrison also co-leads the customer and community workstream of the Equity Alliance, an enterprise-wide initiative focused on addressing systemic racism and health disparities for Black Americans. She has held a series of progressively responsible roles since joining the enterprise in 2011. Prior to her current role, Harrison served as Senior Vice President and Chief Operating Officer for Florida Blue Commercial Markets and GuideWell Innovation. She previously also held roles as Senior Vice President, Chief Customer Officer; Senior Vice President, Chief Customer Experience Officer; Group Vice President, Service and Business Process Management; and Chief of Staff to the Chairman and CEO. Before joining GuideWell and Florida Blue, Harrison was Chief of Staff to the Chairman and CEO at Blue Cross and Blue Shield of Minnesota. She also held a number of leadership positions at Horizon-Blue Cross Blue Shield of New Jersey. Harrison has more than 27 years of health care industry experience with a background in customer service, claims operations, and general business operations, including government programs and client relations. She serves on the boards of Pager, Triple-S Management Corporation, and WebTPA. Harrison also represents Florida Blue as a corporate member of the Florida Blue Foundation, the United Way’s Tocqueville Society, and the American Heart Association’s First Coast Executive Leadership Cabinet. In 2024, she was named to Modern Healthcare’s 2024 Innovators List. Harrison previously served as the Chair of the Florida Blue Foundation and on the boards at GuideWell Source, The Early Learning Coalition of Duval County, and Incepture. She was also the co-chair of the 2018-2019 Go Red for Women Executive Leadership Cabinet. Harrison holds a Bachelor of Science degree in business education from Montclair State University in New Jersey and completed the Advanced Management Program from the University of Chicago Booth School of Business.

James Hereford is President and Chief Executive Officer of Fairview Health Services. He has served in that role for eight years. Based in Minneapolis, Minnesota, Fairview is a $7.3+ billion non-profit integrated health system affiliated with the University of Minnesota through our joint clinical enterprise, M Health Fairview. Fairview’s 34,000+ employees and 5,000+ system providers provide exceptional clinical care, from prevention of illness and injury to caring for the most complex medical conditions. Fairview has proudly served its communities for more than 150 years, and is the fourth largest employer in the State of Minnesota. James provides strategic leadership for Fairview’s entire continuum of services, which is unmatched in the region. Under his leadership, Fairview has grown to one of the most comprehensive and geographically accessible systems in the state, with 10 hospitals—including an academic medical center—serving the greater Twin Cities metro area and north-central Minnesota. Its broad continuum of care also includes 40+ primary care clinics, specialty clinics, senior living communities, retail and specialty pharmacies, pharmacy benefit management services, rehabilitation centers, counseling and home health care services, medical transportation, and an integrated provider network. Fairview is also a leader in addressing health equity issues in Minnesota, including the establishment of the Fairview Hub for Health and Wellness, that brings together partners to address social determinants of care. Prior to joining Fairview, James served as chief operations officer at Stanford Health Care at Stanford University, where Stanford became a top ten hospital nationally during his time there. Previous roles included chief operations officer at the Palo Alto Medical Foundation, and a series of leadership roles with the Group Health Cooperative in Seattle, where he was responsible for leading the creation of one of the first primary care medical home models implemented at scale, the integrative use of technology in care delivery that brought the use of web technology to support patient access to their medical records and connection to their care teams, and the implementation of a lean management and improvement system across an integrated health plan and care delivery system. James holds bachelor's and master's degrees in mathematics from Montana State University. He has taught courses with Stanford University’s Graduate School of Business, University of Washington’s Master of Health Administration program, and The Ohio State University’s Master of Business Operations Excellence program. He is a frequent writer and presenter on the topic of lean management systems and transformation

Bio coming soon!

As the Co-founder and CEO of Oshi Health, Sam is on a mission to increase access to the high quality, whole-person care that two of his family members have needed to manage their digestive conditions. His goal is to free millions of people from the burden of these conditions so they can get back to their life and work. Sam is leading Oshi’s growth and democratizing access to high value digestive care that’s proven to achieve unmatched clinical outcomes, member engagement & satisfaction and cost savings. He has led development of national-scale specialty value-based care contracts that serve as a model for how to pay for outcomes that matter to patients and drive significant cost savings. Having invested in creating robust evidence, Sam is now aligning all healthcare stakeholders to bring this critically needed care to millions of people: Payers provide in-network access to Oshi’s care for their members; employers build awareness of Oshi’s care to improve the health and productivity of their workforce; provider groups partner with Oshi to extend their practices; and patients come to understand their condition and triggers to achieve sustainable control over their symptoms. Under his leadership, Oshi has built a specialized clinical workforce and empowered culture that thrives in delivering true relationship-based care, earning Oshi multiple ‘Best Places to Work’ honors. Prior to co-founding Oshi Health, he held leadership roles across healthcare technology and tech-enabled services companies focused on improving population health. Sam lives in New York City with his family and enjoys comparing notes with other innovators in healthcare and cheering on Philadelphia sports teams and NYCFC.

Bio coming soon!

Bio coming soon!

Rondy is a member of the Public Sector and Infrastructure Group and is responsible for managing Goldman Sachs' strategic advisory practice for nonprofit healthcare organizations. He joined Goldman Sachs as a managing director in 2008. Prior to joining Goldman Sachs, Rondy was a managing director and co-head of the municipal healthcare group at UBS Securities LLC. Rondy began his career at JP Morgan & Co., where he was a managing director and head of its nonprofit healthcare practice. He earned a BA in Economics from Swarthmore College and an MBA from Stanford University.

Laura Jensen spearheads strategic partnerships revolutionizing the way patients access and manage their medications. Operating in a dual role, Laura oversees growth strategies for both Amazon Pharmacy and PillPack's manufacturer and prescriber verticals. Her business team is focused on developing integrated experiences that seamlessly connect pharmacy and prescriber groups, driving efficiencies and improving patient outcomes. Jensen's expertise spans sales, marketing, operations, and commercial innovation honed through leadership roles at prominent pharmaceutical companies like UCB and GlaxoSmithKline. Her unique cross-functional background allows her to approach challenges from multiple angles, fostering collaboration and unlocking new opportunities.

Sarah Johnson is the Chief Operating Officer of Penn Medicine at Home (PMAH), an entity of Penn Medicine which is comprised of home infusion, home health, hospice, palliative care, and community health workers with a combined census over 7,000 patients. Johnson has spent most of her career in health care working first in operations in the Mental Health field in Minnesota. Johnson moved to Penn Medicine where she was the CHRO for Penn Homecare and Hospice Services and subsequently Pennsylvania Hospital before returning to PMAH as their COO. Her responsibilities include strategy, business development, and program integration as well as oversight of Home Infusion. Currently, she is developing programs to expand and diversify the services provided by PMAH. Johnson received her BA from Kenyon College and MBA from The Wharton School. She is an active volunteer serving as the Chair of the Board for VisionLink Philadelphia.

Kim A. Keck is President and Chief Executive Officer of the Blue Cross Blue Shield Association (BCBSA), a national federation of independent, community-based and locally operated Blue Cross and Blue Shield (BCBS) companies. Keck, a respected leader in the healthcare industry, has built a reputation as an engaged, incisive leader. As president and chief executive officer of BCSBA, Keck is focused on driving equity and affordability in health care. This focus has led to partnerships addressing the cost of prescription drugs and dedicated efforts to address the racial disparities in maternal healthcare. Prior to joining BCBSA in 2021, she served as president and CEO of Blue Cross & Blue Shield of Rhode Island (BCBSRI), the state’s largest health insurer. During her tenure at BCBSRI, she drove strategic initiatives around cost and value stewardship, convenience and comprehensive health, and led policy efforts fortifying elements of the Affordable Care Act to ensure all Rhode Islanders have access to quality care. She also combatted long-standing social issues influencing health outcomes, including childhood obesity, housing insecurity and racial inequities. Keck previously spent 28 years at Aetna, where she held leadership roles spanning from head of enterprise strategy to head of investor relations, treasury, tax, actuary, controllers and planning. She served as president of Aetna’s northeast region and interim president of the southeast region and was responsible for $20 billion in revenue and approximately five million members across the commercial and Medicare segments. As a prominent and innovative leader in the industry, Keck was named one of Modern Healthcare’s 100 Most Influential People in Healthcare for 2022 and was recognized on the Who’s Who list in 2023 by Crain’s Chicago Business. Keck graduated with honors from Boston College with a degree in mathematics and earned a Master of Business Administration in finance from the University of Connecticut. She is a CFA charter holder.

A sought-after presenter and prolific author, Jennifer S. Mensik Kennedy, PhD, MBA, RN, NEA-BC, FAAN, serves as the 38th president of the American Nurses Association. In this national leadership role, Mensik Kennedy boldly advocates for the nation’s 5.5 million RNs. In 2023, she was named by Modern Healthcare as one of the 100 Most Influential People in Healthcare. Mensik Kennedy is a sought-after presenter and prolific author based on her insights about and experience involving key nursing issues. Her books include Lead, Drive, and Thrive in the System, 2nd edition, and The Nurse Manager’s Guide to Innovative Staffing, 2nd edition. She co-authored Lead like a Nurse, A Nurse’s Step-By-Step Guide to Transitioning to the Professional Nurse Role, and The Power of Ten, 2nd edition, and contributed a chapter to The Career Handoff: A Healthcare Leader’s Guide to Knowledge & Wisdom Transfer across Generations. Prior to her presidency, Mensik Kennedy held key leadership positions within the nursing profession, including serving the American Nurses Association as Treasurer, Second Vice President, and Director-at-Large. She also served as President of the Arizona Nurses Association from 2007 to 2010. Additionally, Mensik Kennedy held the role of governor of nursing practice for the Western Institute of Nursing in 2010-2014. Mensik Kennedy earned a PhD from the University of Arizona College of Nursing with a focus on health systems and a minor in public administration from the Eller College of Management. She holds an MBA from the University of Phoenix and a BSN from Washington State University. Mensik Kennedy also earned an ADN from Wenatchee Valley College-North. Prior to assuming the presidency of American Nurses Association, she was an associate clinical professor at the Oregon Health and Science University School of Nursing. Mensik Kennedy was inducted in 2014 as a fellow of the American Academy of Nursing. She has been recognized as Alumna of the Year by both University of Arizona College of Nursing and Washington State University College of Nursing.

Dr. Ali Khan is Vice President and Chief Medical Officer (CMO) for Aetna Medicare. In this role, Dr. Khan will continue to advance strategies, policies and programs that drive the delivery of holistic care, and champion work that positively impacts the clinical results and member experience for our more than 11 million Medicare members nationwide. Dr. Khan joins Aetna from Oak Street Health where he is the Chief Medical Officer of Value Based Care Strategy and Executive Medical Director. He works at the intersection of medicine, entrepreneurship, translational health policy, population health and public service to help transform American healthcare delivery and achieve the quadruple aim. On the basis of his work at frontier delivery systems across the United States, Dr. Khan was named a National Minority Quality Forum 40 Under 40 Leader in Health, a MedTech Boston 40 Under 40 Healthcare Innovator and a California HealthCare Foundation (CHCF) Health Leadership Fellow. Prior to Oak Street, he served as CareMore Health's Clinical Design Officer, where he directed national clinical product and program design, implementation and iterative innovation for CareMore's work with high need, complex and vulnerable populations across the United States. During his prior work at Iora Health, Dr. Khan served on the national clinical operations leadership team as Director of Physician Engagement. As a clinical innovator, he led the strategic design and deployment of a variety of initiatives in population health, clinical quality improvement, clinical application product development and workforce development. Dr. Khan is a board-certified internist and practices general internal medicine in both the primary care and inpatient settings. His particular focus: the care for the super-utilizer urban underserved (in Richmond, Boston, New Haven, Las Vegas, San Francisco, San Jose and Chicago) in high-performing frontier healthcare delivery systems. He draws on experiences within leading academic medical centers, the Veterans Healthcare Administration, Kaiser Permanente and the private sector. Beyond the clinic, Dr. Khan maintains an active public leadership portfolio, including recent service on the national boards of Doctors for America, the American College of Physicians, Physicians for Human Rights, the California Healthcare Foundation Leadership Program and Virginia Commonwealth University. He is the Co-Founder of VoteHealth 2020, IMPACT and Doctors for Biden. Dr. Khan completed his residency at Yale-New Haven Hospital, where he served on the clinical faculty. He is a graduate of the Harvard Kennedy School and VCU’s Medical College of Virginia, earning joint MD and MPP degrees as a Harvard Public Service Fellow. Among his many accolades, Dr. Khan was named a Modern Healthcare Top 25 Emerging Leader, a National Minority Quality Forum 40 Under 40 Leader in Health, and a Crain’s Chicago Business Health Care Hero.

David Kim, MD is Chief Executive Officer for the MemorialCare Medical Foundation, a physician organization and part of the not-for-profit MemorialCare Health Systems; a leading Southern California integrated health care delivery system. In his role as CEO, he oversees a network of 110 primary care physicians and over 700 contracted or employed specialist physicians spanning the five-hospital MemorialCare system. He has extensive firsthand experience in physician leadership, implementation of Electronic Health Records for physician groups, performance improvement, and developing and running utilization management programs, disease management programs, and physician compensation systems. Prior to joining MemorialCare, he lead the Clinical Network division of Providence, a $24 billion health system based in Renton, Washington. Spanning seven states across the Western U.S., Providence includes 52 hospitals, over 1,000 clinics and a diverse family of Catholic, other faith-based and mission-driven secular organizations dedicated to enhancing the overall health of the communities served. As Executive Vice President and Chief Executive of the Providence Clinical Network, Dr. Kim leads what was formerly known as Physician Enterprise (medical groups across Providence), the Ambulatory Care Network (same day care including urgent care, ExpressCare, ambulatory surgery and imaging, and partnerships, i.e., Walgreens), and the Clinical Institutes (focused hubs of care, coordination and research for select specialty areas). A family medicine physician by training and now respected physician leader, Dr. Kim has served in several leadership roles across Providence, including Chief Medical Officer and Chief Executive for Providence Medical Foundation - Orange County and High Desert region, where he partnered with physicians and administrators to help grow Providence into one of the largest physician practice management organizations in California. Dr. Kim received his medical degree from the University of Illinois at Chicago, School of Medicine and served his residency at Northridge Hospital Medical Center. He holds a master’s degree in applied physiology from the Chicago Medical School and a Bachelor of Arts degree in philosophy and biology from Northwestern University. Originally from Chicago, Dr. Kim now resides in Tustin, California with his wife of 15 years and three daughters.

Bio coming soon!

Karl Koenig, M.D., M.S., specializes in treatment of hip and knee arthritis including both primary and revision joint replacement surgery. He has a special interest in the treatment of periprosthetic fractures and prosthetic joint infections. Koenig co-leads the integrated practice unit for lower extremity conditions with Kevin Bozic, M.D., and works in developing IPUs for other musculoskeletal conditions. He is also the director of the Joseph Miles Abell Jr., M.D., Clinical Fellowship in Orthopaedic Surgery and leads the initiative to improve access to musculoskeletal care for Austin residents who face barriers to health care.

Bio coming soon!

Rob Lemos is Millennium Physician Group’s Senior Vice President of Strategy and Growth. Business Development, practice integration, strategy and organic growth are his teams’ focus areas. In the 3 years since Rob joined Millennium, his team has grown Millennium’s provider base by 49% and risk membership by 40%. Rob comes to Millennium from Atlanta, where he held business development and growth positions with Privia Health from 2014-2020. He has a strong background in the Primary Care space and is passionate about the physician and patient experience. Going forward, Rob and his team are focused on opportunities with physicians and hospital partners to expand MPG’s impact across Florida, Georgia, North Carolina, Texas and beyond.

Scott is a growth-oriented leader with experience in value-based and kidney care. At Evergreen, Scott leads the growth and strategy of the business. He has deep experience working in joint ventures and navigating complex legal and compliance issues. Prior to joining Evergreen, Scott was the General Manager for DaVita Labs where the team implemented PCR testing and maintained continuous operations during the Public Health Emergency. Prior to DaVita Labs, Scott led DaVita’s Corporate Develop team where they were charged with meeting growth goals in value-based care initiatives and dialysis treatment volume. Scott got his start in value-based care leading the implementation of BPCI programs in the post-acute space.

Bio coming soon!

Bio coming soon!

Bio coming soon!

Bio coming soon!

Bio coming soon!

Megan O’Reilly is the Vice President for Health and Family issues in AARP’s Government Affairs Office. During her seven years with the organization, she and her team have led AARP's advocacy on issues including, Medicare, prescription drugs, family caregiving, Medicaid, the Affordable Care Act, long-term care and food security. Prior to joining AARP, Megan was the Director in the Office of Legislation at the Centers for Medicare & Medicaid Services (CMS) and spent more than a decade working on Capitol Hill, including as staff director for the House Education & Labor committee. Throughout her career, Megan has worked on key legislative initiatives including the Affordable Care Act, the Lilly Ledbetter Fair Pay Act and most recently, the prescription drug provisions in the Inflation Reduction Act. She holds a JD from DePaul University and a BA from American University.

Marcus Osborne serves as Chairman of RightMove, created by the Hospital for Special Surgery, focused on changing the approach to musculoskeletal care for Americans. Previously, Marcus served as Senior Vice President of Health Transformation at Walmart, focused on furthering Walmart’s goal of improving healthcare access and affordability for consumers. Prior to Walmart, Osborne served as the CFO of the Clinton Foundation Health Access Initiative, helping increase access to HIV/AIDS treatment in the developing world. Marcus serves on the Board of several companies, including WebPT. He attended the Harvard Business School and received his Master’s in Business Administration, graduating with honors.

Bio coming soon!

Dr. Kathryn Rexrode is the Chief of the Division of Women’s Health in the Department of Medicine at Brigham and Women’s Hospital (BWH) and a Professor of Medicine at Harvard Medical School. She also serves as the Director of the Office for Women’s Careers in the Center for Center for Diversity and Inclusion at BWH and is a practicing women’s health primary care physician. Dr. Rexrode is the Director of the Gretchen and Edward Fish Center for Women’s Health which provides comprehensive women’s health services, including 14 specialties and a dedicated clinic for menopause and midlife care. Building on its core mission of leading the field in state-of-the-art care for women, the Division of Women’s Health also conducts translational women’s health research and leads innovative education programs for medical students, residents, and faculty to advance the health of women. Dr. Rexrode has broad and deep research experience in women’s health and is the author of more than 300 research publications. She leads multiple research studies funded by the National Institutes of Health with a focus on the impact of metabolism and female-specific risk factors on the risk of heart disease and stroke in women. She has received multiple scientific and mentorship awards. Dr. Rexrode is the current Director of the Brigham Research Institute and former Chair of the American Heart Association Women and Underserved Populations Committee.

Bio coming soon!

Lindsay Jurist-Rosner is the Co-founder and CEO of Wellthy – a market-leading health care concierge company combining digital innovation and human expertise so that families have the support they need to navigate any care situation. Two million people have access to Wellthy through some of the largest health plans and employers, including Best Buy, Meta, and Hilton. With Wellthy, Lindsay is building the company she needed throughout the 28 years she cared for her mother. Wellthy was selected as one of Fast Company’s “10 Most Innovative Workplace Companies,” and Lindsay was named to Inc. Magazine’s “Female Founders 200” list. Lindsay’s written for Fortune and Good Housekeeping, and has spoken at numerous panels and conferences, including at the 2024 Wall Street Journal Health Forum. Lindsay lives in New York City with her husband and four kids.

Bio coming soon!

Jennifer L. Schwartz, Esq., is the Chief Strategy and Legal Officer, reporting directly to President and CEO Janice E. Nevin, M.D., MPH. As chief strategy officer she is a core member of ChristianaCare’s senior leadership team and is responsible for driving the strategic plan and future vision of the organization and identifying and pursuing opportunities tied to achieving the strategic plan. She is also the Chief Legal Officer for the system providing counsel to the senior leadership team and Board of Directors. She serves as health system corporate secretary and staff to the Board of Directors and committees of the Board. Population Health, Corporate Compliance, the Center for Virtual Health and the Gene Editing Institute also report to Schwartz. Schwartz’s last post was as vice president of legal affairs and general counsel for Lourdes Health System and chief executive director of the LHS Health Network ACO. As general counsel at Lourdes, Schwartz was responsible for all legal matters at a three-hospital health system, participated in the oversight of health system operations and led strategic revenue-generating initiatives. As chief executive director of the LHS Health Network ACO she was responsible for leading the strategy, operations and performance of the network, eventually building the organization to be one of the largest primary care physician networks in New Jersey. Prior to joining Lourdes, she was a partner in the law firms of Fox Rothschild, LLP, and Gluck Walrath, LLP, where she represented acute care hospitals and providers in a wide range of areas, such as new models of care under health care reform; physician-alignment strategies; third-party reimbursement, including Medicare and Medicaid; federal and state regulatory compliance; certificate of need; strategic hospital affiliations, including joint operating arrangements; and risk management. Schwartz received her law degree from Widener University School of Law and her undergraduate degree from Denison University in Ohio.

Dr. Neel Shah, MD, MPP, FACOG, is Chief Medical Officer of Maven Clinic, the largest virtual clinic for women's and family health, and visiting scientist at Harvard Medical School. He is a globally recognized expert in designing solutions that improve health care, and is listed among the "40 smartest people in health care" by the Becker's Hospital Review. His work to build equitable, trustworthy systems of care has been profiled by the New York Times, Good Morning America, and other outlets, and is featured in the documentaries “Color of Care,” produced by Oprah Winfrey, and “Aftershock,” which is currently streaming on Hulu. Dr. Shah has written more than 50 peer-reviewed academic papers and contributed to four books, including as senior author of Understanding Value-Based Healthcare (McGraw-Hill), which Don Berwick has called "an instant classic" and Atul Gawande called "a masterful primer for all clinicians." Prior to joining the Harvard faculty, Dr. Shah founded Costs of Care, an NGO that curates insights from clinicians and patients to help delivery systems provide better care. In 2017, he co-founded the March for Moms Association, a coalition of more than 20 leading organizations, to increase public and private investment in the wellbeing of mothers. Dr. Shah serves on the advisory board of the National Institutes of Health, Office of Women's Health Research.

Tina Shah is a practicing pulmonary and critical care physician and national expert in workforce burnout, digital health, and health policy. She is the Chief Clinical Officer of Abridge, a generative AI company that is cutting down time spent on administrative work for clinicians and empowering patients. Prior to this role, Dr. Shah served in two White House Administrations and the US Dept. of Veterans Affairs, and more recently as Senior Advisor to the current US Surgeon General where she created nation’s strategy to address the great resignation and burnout in healthcare. During the early part of the COVID pandemic, Dr. Shah stood up telemedicine for a large health system in GA and led emergency response across tribal hospitals. As national expert on burnout and healthcare, she has been featured at the National Academy of Medicine, Centers for Medicare and Medicaid Services, Harvard and CBS and NBC news. Dr. Shah received her MD from Thomas Jefferson University and her MPH from Harvard. When not contemplating life’s larger questions, she enjoys playing volleyball and spending time with her family.

Abhinav Shashank is the Chief Executive and Co-founder of Innovaccer, a San Francisco-based healthcare technology company on a mission to revolutionize healthcare through innovative technology solutions. Committed to bringing joy back to the practice of medicine and patient care, Abhinav has established himself as an influential strategist with a track record of driving transformative change in the healthcare industry. Under his leadership, Innovaccer has garnered recognition as a national leader in population health management, with over 30 awards and 90 analyst recognitions. Abhinav's initiatives have resulted in $1B in cumulative cost savings and partnerships with 60+ healthcare organizations. His strategic innovations led to a $3.2 billion valuation and $375 million in total capital raised. Abhinav's influence extends to thought leadership, with over 300 published articles and recognition in “Modern Healthcare’s 40 under 40”, Forbes' "30 Under 30 Asia: Enterprise Tech”, Becker's Hospital Review's "Top 60 rising leaders in U.S. healthcare under 40”, and “Fortune India 40 under 40”. He envisions a future where healthcare becomes 100% consumer-centric and value-driven, leveraging technology for enhanced engagement and outcomes

Ran Shaul is the Co-Founder and Chief Product Officer of K Health, the AI-driven Primary Care company on a mission to give everyone access to high-quality healthcare. Its 24/7 virtual primary care solution is available to millions of people in the U.S. through leading health systems and insurers, as well as through a direct-to-consumer mobile app. K Health’s platform includes a medical chat and AI predictive models based on large datasets to help physicians optimize diagnosis and treatment, and focus on patient care. Prior to founding K Health he co-founded Pursway, a leading marketing insights company (Acquired by IPG Mediabrands, NYSE: IPG). Ran hold a Bs.C in Industrial Engineering from Tel Aviv University.

Dan leads Oliver Wyman’s Provider Team within the Health and Life Sciences practice, working health systems, ambulatory groups, innovators and payers to drive change in the US health care system. Dan has been with Oliver Wyman since 2008, when he joined as part of the ChapterHouse acquisition – a pivotal event in the formation of the HLS practice. Initially focusing on health insurance and reform, Dan sought to have greater impact on health care transformation and helped launch the Provider Team in 2012, becoming its lead in 2015. Dan and the team grew the Provider business quickly by initially advising providers on value-based care pathways, but then quickly expanding into transformational enterprise strategies. Now fully at scale, the Provider Team collaborates with clients on efforts spanning enterprise strategy, operational transformation, digital enablement, organizational effectiveness, and external partnerships. Dan graduated from the University of Michigan (with high honors // Phi Beta Kappa), receiving his Bachelor of Business Administration in Finance & Marketing. He went on to receive his MBA from the Fuqua School of Business at Duke University. As one of the most senior leaders in the HLS practice, Dan mentors, guides and supports the team in building out new capabilities to drive ever greater client impact. While the ails of the US healthcare system are well documented, Dan has found that real change can happen, and that it can improve the lives of patients, providers while also delivering on quality, safety and cost measures. His open, collaborative approach and transparent communication style have helped Dan and his team partner with health systems, provider groups and innovators across the country. Based in Chicago, Dan enjoys pretty much any athletic/outdoor endeavor, and he is chronically testing and adopting life/fitness/food hacks. All that aside, he’s happiest spending time with his family and friends traveling, skiing, and otherwise adventuring.

Bio coming soon!

Ran is a Partner in Oliver Wyman’s Health & Life Sciences Practice, works across the Payer and Providers domains, specializing in the latter. He has spent the last 15 years in advising large care delivery providers, health insurers and new entrants to the industry. Relevant Experience •For a regional health system, Ran led the development of a multi-year strategy, centered on becoming a leading population health manager in the area, improving consumer experience and driving growth. As part of the work, the operating mode land the physician structure have been diagnosed and radically redesigned to align with PHM objectives. •A large regional provider was embarking on a volume to value transformation. The client needed a complete strategy development, integrating existing plans and capabilities into a 5-year roadmap plan. Ran had a key role in developing the client’s approach and strategy to re-design its primary and specialty care models to become a true population health manager •For a regional healthsystem, Ran developed a new design and implementation structure for its Independent Physician Association. The design included a differentiated value proposition for providers, a service and support model to the physicians and the financial structures required to fund the and incentivize efforts. •Ran led a comprehensive corporate strategy development for a top-tier regional health system that examined market positioning, market and external dynamics – current and future and charted several future market scenarios. The team then articulated a unique, differentiated value proposition for the client and a related growth strategy, aiming to drive significant growth in the face of declining reimbursements and increasing costs •For a regional health system, Ran led a service line business planning and operating model restructuring aimed to reduce cost and drive profitable growth. The plans included elements of footprint expansion and rationalization, independent provider partnership and alignment, scope of services updates, marketing and branding. In addition, a long-term revamped operating model and a hybrid accountability structure with hospital operations and medical group was put in place •For a suburban regional health system, Ran led an OW team which developed, in close collaboration with the client an innovative ‘new front door’ for the client, focused on a combination of physical and digital ambulatory access points across the communities served. These new modalities of care expanded on the traditional definition of ‘sick care’ to engage patients in their daily lives in a digital manner and provide them personalized access options on their terms •A regional health systems was facing challenging reimbursement and cost dynamics and required a significant change to its way of working to optimize its cost structure and ignite growth. Ran led a large team of consultants and clinical subject matter experts in diagnosing the current state of operations, followed by an intense, collaborative development of the future state and the implementation plan. The OW team left the client with a ready to implement and widely accepted plan to realize up to 5 percentage points improvement of its current operating margin within the next 3 years. Prior to Oliver Wyman, Ran spent 5 years working for Tefen Management Consulting in Israel and the US. Through global engagements across numerous industries, including Healthcare, Ran led project teams in the implementation of business process re-design and the achievement of Operational Excellence. Ran holds a BSc from Shenkar College of Engineering and Design in Israel and a Six Sigma Black Belt certification from the American Society of Quality. Prior to academic education, Ran served for 6 years in the Israeli Navy.

Amy works with leadership of global strategic clients, resources across Google and partners in the cloud eco-system to identify and deliver transformative digital solutions. She also serves as a point of contact for internal resources, alliance partners and industry affiliations on healthcare and life sciences trends/issues. Recent speaking topics include healthcare transformation opportunities with GenAI, healthcare regulatory issues, delivering on the patient experience, leveraging technology to bridge healthcare inequities, women in tech, and meeting compliance and security requirements through use of cloud technology. Prior to joining Google, Amy spent 20 years working with PwC in New York, Chicago and San Francisco, leading market growth strategies. Afterwards, Amy became a partner at The Chartis Group, a mission based healthcare advisory firm. Amy and her teams have been recipients of several awards including: 5 AVA gold awards for digital innovations, The Financial Communications Society’s "Differentiating a 21st Century Professional Services Firm" award and the Brandon Hall "Excellence in Learning" award. In addition, Amy has been the recipient of the President's Council on Service and the National Service to Youth Awards. Amy has an undergraduate degree from the University of Pittsburgh and an MBA in technology and strategy from Loyola University of Chicago. She's actively engaged in female, youth and minority mentoring, has served on the ULC and San Francisco Boys and Girls Club Boards, is on the National Make-A-Wish Board, the American Health Association Chicago Heart Ball Board and serves on the Advisory Board to the Dean at Loyola University.

Sam Yamoah drives Cambia’s strategic framework to serve customers with innovative health care solutions. With deep experience in strategic business building in health insurance, systems, and technology. Sam has a history of bringing teams together to solve some of health care’s toughest challenges. Sam came to Cambia most recently from McKinsey and Company, where he was an associate partner and leader in the healthcare and public sector practice providing counsel to clients on top-management agenda topics. His primary focus areas included strategy, profitable growth, and large-scale performance transformations. Before McKinsey, he held product development and process-improvement roles at McKesson Corporation. Sam is passionate about service and improving health disparities. He was the health care leader for McKinsey’s Institute for Black Economic Mobility, a research institute and think tank dedicated to advancing racial equity and inclusive growth globally. Sam grew up in Liberia and Ghana and came to the U.S. to pursue his education. He received an MBA from The University of Chicago and a bachelor’s degree from Luther College. He co-founded a non-profit organization that distributes books to schools, libraries, and other learning centers in Ghana.

Daniel Yang is the vice president of Artificial Intelligence and Emerging Technologies for Kaiser Foundation Health Plan, Inc. and Hospitals. Dr. Yang is spearheading Kaiser Permanente’s work to advance responsible AI. Under his leadership, Kaiser Permanente is plotting a course of responsible AI use that advances the organization’s mission of providing high-quality, affordable care for its 12.5 million members and improving the health of its communities. In his role, Dr. Yang ensures that the organization is applying AI in ways that are safe, dependable, accurate, and equitable. He establishes quality oversight for all AI applications across the organization, including those used in clinical operations, research, education, and related administrative functions. He also partners with teams across the organization to develop structures and processes to evaluate, prioritize, manage, and monitor AI applications. Prior to Kaiser Permanente, Dr. Yang was the program director of patient care at the Gordon and Betty Moore Foundation, where he founded and led a $120 million philanthropic program focused on diagnostic excellence. In this capacity, he helped to establish several public-private partnerships to promote the responsible use of AI in health care, including the National Academy of Medicine’s Health Care AI Code of Conduct, the Coalition for Health AI, and the Health AI Partnership. Dr. Yang has created public-good infrastructure to support the development, implementation, and evaluation of diagnostic AI algorithms, including publicly accessible clinical datasets and third-party evaluation services to independently assess algorithm performance. He has also advanced research methods for rigorously evaluating the clinical impact of AI and machine learning algorithms in real-world settings. In addition, he represents Kaiser Permanente as a member of the US AI Safety Consortium and the Coalition for Health AI. Dr. Yang is a practicing internal medicine physician. He completed his undergraduate and medical degrees at the University of Illinois Chicago, his internal medicine residency at the University of California, San Francisco, and a fellowship in health care systems design at Stanford University.

Rachel is a partner in the Health and Life Sciences Practice at Oliver Wyman. She has deep experience across the healthcare ecosystem, helping insurance, care delivery, healthcare technology, and biopharmaceutical companies develop and implement growth and diversification strategies. Rachel is passionate about helping clients provide high-quality and affordable experiences to their customers, and she delights in helping organizations do the unexpected to advance their strategies and the health of their communities. Before joining Oliver Wyman, she worked at Collective Health, a health benefits startup backed by venture capital. Rachel has a PhD in Synthetic Chemistry from the University of California, Berkeley, where she worked under the guidance of Professor Dean Toste on developing innovative transition metal-catalyzed organic reactions and synthesizing complex molecules.